BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12077439)

  • 1. Structure of the C-terminally truncated human ProMMP9, a gelatin-binding matrix metalloproteinase.
    Elkins PA; Ho YS; Smith WW; Janson CA; D'Alessio KJ; McQueney MS; Cummings MD; Romanic AM
    Acta Crystallogr D Biol Crystallogr; 2002 Jul; 58(Pt 7):1182-92. PubMed ID: 12077439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of human MMP9 in complex with a reverse hydroxamate inhibitor.
    Rowsell S; Hawtin P; Minshull CA; Jepson H; Brockbank SM; Barratt DG; Slater AM; McPheat WL; Waterson D; Henney AM; Pauptit RA
    J Mol Biol; 2002 May; 319(1):173-81. PubMed ID: 12051944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structures of MMP-9 complexes with five inhibitors: contribution of the flexible Arg424 side-chain to selectivity.
    Tochowicz A; Maskos K; Huber R; Oltenfreiter R; Dive V; Yiotakis A; Zanda M; Pourmotabbed T; Bode W; Goettig P
    J Mol Biol; 2007 Aug; 371(4):989-1006. PubMed ID: 17599356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor.
    Moy FJ; Chanda PK; Chen JM; Cosmi S; Edris W; Levin JI; Powers R
    J Mol Biol; 2000 Sep; 302(3):671-89. PubMed ID: 10986126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity.
    Bein K; Simons M
    J Biol Chem; 2000 Oct; 275(41):32167-73. PubMed ID: 10900205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes.
    Chen L; Rydel TJ; Gu F; Dunaway CM; Pikul S; Dunham KM; Barnett BL
    J Mol Biol; 1999 Oct; 293(3):545-57. PubMed ID: 10543949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution structure of the catalytic domain of human collagenase-3 (MMP-13) complexed to a potent non-peptidic sulfonamide inhibitor: binding comparison with stromelysin-1 and collagenase-1.
    Zhang X; Gonnella NC; Koehn J; Pathak N; Ganu V; Melton R; Parker D; Hu SI; Nam KY
    J Mol Biol; 2000 Aug; 301(2):513-24. PubMed ID: 10926524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The intermediate S1' pocket of the endometase/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modeling.
    Park HI; Jin Y; Hurst DR; Monroe CA; Lee S; Schwartz MA; Sang QX
    J Biol Chem; 2003 Dec; 278(51):51646-53. PubMed ID: 14532275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors.
    Lovejoy B; Welch AR; Carr S; Luong C; Broka C; Hendricks RT; Campbell JA; Walker KA; Martin R; Van Wart H; Browner MF
    Nat Struct Biol; 1999 Mar; 6(3):217-21. PubMed ID: 10074939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of human neutrophil collagenase reveals large S1' specificity pocket.
    Stams T; Spurlino JC; Smith DL; Wahl RC; Ho TF; Qoronfleh MW; Banks TM; Rubin B
    Nat Struct Biol; 1994 Feb; 1(2):119-23. PubMed ID: 7656015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-ray structure of a hydroxamate inhibitor complex of stromelysin catalytic domain and its comparison with members of the zinc metalloproteinase superfamily.
    Dhanaraj V; Ye QZ; Johnson LL; Hupe DJ; Ortwine DF; Dunbar JB; Rubin JR; Pavlovsky A; Humblet C; Blundell TL
    Structure; 1996 Apr; 4(4):375-86. PubMed ID: 8740360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme.
    Becker JW; Marcy AI; Rokosz LL; Axel MG; Burbaum JJ; Fitzgerald PM; Cameron PM; Esser CK; Hagmann WK; Hermes JD
    Protein Sci; 1995 Oct; 4(10):1966-76. PubMed ID: 8535233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for the highly selective inhibition of MMP-13.
    Engel CK; Pirard B; Schimanski S; Kirsch R; Habermann J; Klingler O; Schlotte V; Weithmann KU; Wendt KU
    Chem Biol; 2005 Feb; 12(2):181-9. PubMed ID: 15734645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-ray structure of human proMMP-1: new insights into procollagenase activation and collagen binding.
    Jozic D; Bourenkov G; Lim NH; Visse R; Nagase H; Bode W; Maskos K
    J Biol Chem; 2005 Mar; 280(10):9578-85. PubMed ID: 15611040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refined 2.0 A X-ray crystal structure of the snake venom zinc-endopeptidase adamalysin II. Primary and tertiary structure determination, refinement, molecular structure and comparison with astacin, collagenase and thermolysin.
    Gomis-Rüth FX; Kress LF; Kellermann J; Mayr I; Lee X; Huber R; Bode W
    J Mol Biol; 1994 Jun; 239(4):513-44. PubMed ID: 8006965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structures of the catalytic domain of human stromelysin-1 (MMP-3) and collagenase-3 (MMP-13) with a hydroxamic acid inhibitor SM-25453.
    Kohno T; Hochigai H; Yamashita E; Tsukihara T; Kanaoka M
    Biochem Biophys Res Commun; 2006 May; 344(1):315-22. PubMed ID: 16603129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical characterization and structure determination of a potent, selective antibody inhibitor of human MMP9.
    Appleby TC; Greenstein AE; Hung M; Liclican A; Velasquez M; Villaseñor AG; Wang R; Wong MH; Liu X; Papalia GA; Schultz BE; Sakowicz R; Smith V; Kwon HJ
    J Biol Chem; 2017 Apr; 292(16):6810-6820. PubMed ID: 28235803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of an active form of human MMP-1.
    Iyer S; Visse R; Nagase H; Acharya KR
    J Mol Biol; 2006 Sep; 362(1):78-88. PubMed ID: 16890240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity.
    Bode W; Reinemer P; Huber R; Kleine T; Schnierer S; Tschesche H
    EMBO J; 1994 Mar; 13(6):1263-9. PubMed ID: 8137810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases: fold and function of their catalytic domains.
    Tallant C; Marrero A; Gomis-Rüth FX
    Biochim Biophys Acta; 2010 Jan; 1803(1):20-8. PubMed ID: 19374923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.